Wisconsin circuit courts

CHD Says Upcoming Court Hearing is Critical in ICU Doctor’s Lawsuit to Decide if Physicians or Hospital Administrators Determine Treatment for Critically Ill COVID-19 Patients

Retrieved on: 
Wednesday, November 17, 2021
Patient, FLCCC, Circuit court, Children's Health Defense, Complaint, Sentara Healthcare, Eastern Virginia Medical School, MD, City, COVID-19, Wisconsin circuit courts, Critical care, Physician, ICU, Health, Research, GLOBE, Hippocratic Oath, CHD, Ivermectin, Hospital, Division, Sentara Norfolk General Hospital, COVID, Medicine, Pharmaceutical industry

Its shocking that physicians arent being allowed to practice medicine, said Childrens Health Defense (CHD) president and general counsel Mary Holland.

Key Points: 
  • Its shocking that physicians arent being allowed to practice medicine, said Childrens Health Defense (CHD) president and general counsel Mary Holland.
  • This is an extremely importantcase, both for patients in critical care and for the physicians devoted to the ethical practice of medicine.
  • This case is about whether a hospital administration can legally prohibit critically ill COVID-19 patients from receiving information and treatment, if they and their doctors so decide it is medically appropriate for them.
  • Their MATH+ Hospital Treatment Protocol introduced in March 2020, has saved thousands of patients who were critically ill with COVID-19.

FLCCC Tells Children’s Health Defense: World’s Leading ICU Doctor Files Lawsuit Against Hospital System After Being Barred from Administering Proven COVID-19 Treatments

Retrieved on: 
Wednesday, November 10, 2021
Mortality, ICU, Ivermectin, Complaint, First Nations in Ontario, Evidence-based medicine, Eastern Virginia Medical School, Critical care, Circuit court, Sentara Norfolk General Hospital, Fluvoxamine, Division, Hospital, Isabella Tree, COVID, COVID-19, Research, Clinical study design, Wisconsin circuit courts, Patient, GLOBE, City, Children's Health Defense, Hippocratic Oath, Death, Physician, United Nations, Ill, FDA, FLCCC, Pharmaceutical industry

Corporations and faceless bureaucrats should not be allowed to interfere with doctor-patient decisions, especially when it can result in harm or death."

Key Points: 
  • Corporations and faceless bureaucrats should not be allowed to interfere with doctor-patient decisions, especially when it can result in harm or death."
  • according to Paul Marik, MD, chief, Division of Pulmonary & Critical Care Medicine, Eastern Virginia Medical School, who practices in the Sentara Norfolk General Hospital.
  • I refuse to watch another patient die from COVID-19 knowing that I was not allowed to give them proven treatments that could have saved their life.
  • Their MATH+ Hospital Treatment Protocol introduced in March 2020, has saved thousands of patients who were critically ill with COVID-19.

John Huffington Seeks Pardon from Maryland Governor Hogan

Retrieved on: 
Tuesday, November 9, 2021
Crime, Ropes & Gray, Maryland Court of Appeals, Death row, Wisconsin circuit courts, Lawyer, DNA, Circuit court

WASHINGTON, Nov. 9, 2021 /PRNewswire/ -- John Huffington announced today that he is seeking a pardon from Maryland Governor Larry Hogan to clear his name of crimes that he did not commit, for which he spent 32 years in prison 10 of which were spent on Death Row.

Key Points: 
  • WASHINGTON, Nov. 9, 2021 /PRNewswire/ -- John Huffington announced today that he is seeking a pardon from Maryland Governor Larry Hogan to clear his name of crimes that he did not commit, for which he spent 32 years in prison 10 of which were spent on Death Row.
  • "By pardoning me, Governor Hogan can correct the injustices I have suffered and clear my name."
  • A pardon by Governor Hogan would be an important step on the path to right the injustices done by Mr. Cassilly and helping to relieve Mr. Huffington of the burdens of his wrongful conviction.
  • "Despite spending the most formative decades of his life wrongfully incarcerated, Mr. Huffington lives a positive life of service to others.I strongly urge Governor Hogan to pardon Mr. Huffington and in doing so, right the wrongs that have tainted his name for too long."

From the Tax Law Offices of David W. Klasing - The 11th Circuit Agrees that Reckless Conduct is Sufficient to Subject Taxpayers to the Foreign Bank Account Willful Failure to Report Penalty

Retrieved on: 
Tuesday, November 2, 2021
Safety, CPAS, EAS, Fair Credit Reporting Act, Tax law, Uniformity and jurisdiction in U.S. federal court tax decisions, Wisconsin circuit courts, Element, Bank, Legislation, Federal, Government, Bank Secrecy Act, Bank account, Crime, Circuit court, Multimedia, IRS, FBAR, Transnational organized crime, Online gambling, Private investigator, Tax advisor

The 11th Circuit recently affirmed a district court's decision to grant summary judgment in favor of the government in a FBAR civil penalty collection case.

Key Points: 
  • The 11th Circuit recently affirmed a district court's decision to grant summary judgment in favor of the government in a FBAR civil penalty collection case.
  • The 11th Circuit Court's decision means that the government can cast a wider net in assessing willful FBAR penalties.
  • If you are the subject of an IRS action, call the Tax Law Offices of David W. Klasing at (800) 681-1295 or schedule online here .
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/from-the-tax-law-offices-of-dav...
    SOURCE Tax Law Offices of David W. Klasing, PC

EYECITY.COM, INC. OBTAINS TEMPORARY INJUNCTION IN SHAREHOLDER DISPUTE

Retrieved on: 
Thursday, October 14, 2021
Safe harbor, OTC Markets Group, ICTY, Securities Exchange Act of 1934, Common stock, Disclosure, OTC, Security (finance), Wisconsin circuit courts, Securities Act of 1933, Court, Circuit court, LTD, GLOBE, U.S. Securities and Exchange Commission, Case Information Statement

The Temporary Injunction prevents the named Defendants from transferring or selling any of the Companys Common Stock, pending a final determination of the Companys claims that all of the Shares issued to these Defendants were fraudulently obtained.

Key Points: 
  • The Temporary Injunction prevents the named Defendants from transferring or selling any of the Companys Common Stock, pending a final determination of the Companys claims that all of the Shares issued to these Defendants were fraudulently obtained.
  • Additional information concerning this case and the Court Documents are available online from the Circuit Court of Pasco County, Florida, under Case No.
  • 2021CA001726CAAXES
    Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Catalyst Pharmaceuticals Receives Positive Decision from Appeals Court That Supports Orphan Drug Exclusivity for Firdapse® for LEMS

Retrieved on: 
Thursday, September 30, 2021
Orphan Drug Act of 1983, ALL, Food, New Drug Application, Orphan, Hope, Parent, Annual report, FDA, Virginia General District Court, Patient, Wisconsin circuit courts, Physician, CORAL, Adult, LEMS, Degenerative disease, Court, Myasthenia gravis, CEO, Circuit court, Tablet, District court, Amifampridine, Health Canada, Disease, IND, Catalyst Pharmaceuticals, Jacobus, Lambert–Eaton myasthenic syndrome, R, Forward-looking statement, Investment, District, Nasdaq, Orphan drug, Time, SEC, GLOBE, Pharmaceutical industry, Medicine

The Court's decision adopted Catalysts core argument that the FDAs approval of Ruzurgi violated Catalyst's rights to Orphan Drug Exclusivity.

Key Points: 
  • The Court's decision adopted Catalysts core argument that the FDAs approval of Ruzurgi violated Catalyst's rights to Orphan Drug Exclusivity.
  • This decision increases the hope for the patients living with these diseases that one day soon an approved drug for their rare disease might be a reality.
  • Firdapse is currently being evaluated in clinical trials for the treatment of MuSK-MG and has received Orphan Drug Designation from the FDA for myasthenia gravis.
  • Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.

MSP Recovery Files Whistleblower Lawsuit Against 315 Auto Insurers

Retrieved on: 
Wednesday, August 18, 2021
Legal, Professional Services, Behavior, Privacy, Materiality, Proxy, LCAP, SEC, Farmers Insurance Group, Southern Division, Agreement, Securities Act of 1933, Risk, District court, Centers for Medicare & Medicaid Services, Solution, Health, Wisconsin circuit courts, Center, Failure, Securities Exchange Act of 1934, U.S. Securities and Exchange Commission, Communication, CMS, Circuit, Douglas v. U.S. District Court ex rel Talk America, Probability, Prospectus, History, Sale, Liberty Mutual, Social, Circuit court, Industry, Farmer, Legislation, Form, Insurance, Government, Nasdaq, Person, Name, SCHIP, MSP, Goal, Complaint, PLC, THE, Lawyer, Eleventh, IDS, LLC, Private Securities Litigation Reform Act, Assignor estoppel, Growth, Acquisition, Lionheart, Federation, Social Security, News, Compliance, COVID-19, Budget, Health insurance, Risk management, Security (finance), MSP Recovery, Lionheart Acquisition Corporation II, MSP RECOVERY, LIONHEART ACQUISITION CORPORATION II

The action was filed by MSP Recovery Law Firm (MSP Law), and Akeel & Valentine, PLC on behalf of MSP WB, LLC (MSP WB), a subsidiary of MSP Recovery.

Key Points: 
  • The action was filed by MSP Recovery Law Firm (MSP Law), and Akeel & Valentine, PLC on behalf of MSP WB, LLC (MSP WB), a subsidiary of MSP Recovery.
  • MSP Law is a separate legal entity from MSP Recovery.
  • In its whistleblower suit on behalf of the federal government and the Subject Jurisdictions, MSP Recovery alleges that the auto insurers intentionally developed a scheme through the filing of known false reports.
  • This case is based on what MSP Recovery has seen over the last seven years as auto insurers knowingly and willfully turn a blind eye and evade their obligations to Medicare, said John H. Ruiz, founder of MSP Recovery and MSP Law and the lead attorney representing MSP Recovery.